Orthobiologics

The PROPEL registry was initiated in March 2022 to gather real-world data from patients who have been treated with OssDsign...

CartiHeal announced the first commercial implantation of Agili-C in the U.S. The Agili-C implant features a bi-phasic design that supports both...

The engineered allogenic osteochondral graft has shown promise in preclinical studies and could benefit people with damaged knee cartilage caused...

The recall relates to bone repair products made from human tissue that are used primarily in orthopedic and spinal procedures....

Kuros completed enrollment in the STRUCTURE trial, investigating Fibrin-PTH (KUR-113) in single-level transforaminal lumbar interbody fusion....

Improvements to CERAMENT G antibiotic-eluting bone graft substitute have been made to increase ease of use and reduce environmental impact....

New Precise technology is designed to provide physicians with more options for custom platelet-rich plasma....

BIO-REIGN 3D provides an ideal microenvironment for cell proliferation and vascularization leading to regeneration of healthy bone. ...

LDGraft is a next-generation bone graft substitute for spinal fusion, with encapsulated rhBMP-2 for controlled and extended release....

OssDsign Catalyst is a nanosynthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries....